What's New at CBER You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA) The following links have been updated recently: Posted: 7/30/2021 July 16, 2021 Summary Basis for Regulatory Action - VAXNEUVANCE Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA